EP 1267872 A2 20030102 - FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH ANTI-TUMOR ANTHRACYCLINE DERIVATIVES
Title (en)
FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH ANTI-TUMOR ANTHRACYCLINE DERIVATIVES
Title (de)
KOMBINATION VON FARNESYL PROTEINTRANSFERASE INHIBITOREN MIT ANTITUMOR WIRKSAMEN ANTHRACYCLINDERIVATEN
Title (fr)
COMBINAISONS D'INHIBITEURS DE FARNESYL PROTEINE TRANSFERASE ET DE DERIVES ANTITUMORAUX D'ANTHRACYCLINE
Publication
Application
Priority
- EP 01917033 A 20010226
- EP 0102166 W 20010226
- EP 00200696 A 20000229
Abstract (en)
[origin: WO0164197A2] The present invention is concerned with combinations of a farnesyl transferase inhibitor and an anthracycline derivative for inhibiting the growth of tumor cells and useful in the treatment of cancer.
IPC 1-7
IPC 8 full level
C07D 487/04 (2006.01); A61K 31/47 (2006.01); A61K 31/4725 (2006.01); A61K 31/519 (2006.01); A61K 31/70 (2006.01); A61K 31/704 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 401/06 (2006.01)
CPC (source: EP)
A61K 31/47 (2013.01); A61K 31/70 (2013.01); A61K 31/704 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 0164197A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0164197 A2 20010907; WO 0164197 A3 20020321; AU 4416701 A 20010912; CA 2397253 A1 20010907; EP 1267872 A2 20030102; JP 2003525237 A 20030826
DOCDB simple family (application)
EP 0102166 W 20010226; AU 4416701 A 20010226; CA 2397253 A 20010226; EP 01917033 A 20010226; JP 2001563094 A 20010226